POST MARKETING CLINICAL (PMC)

About the Role

Phase IV studies are required as a condition of market approval. Pharmaceutical companies conduct post-marketing studies to improve the potential of marketed products. This phase is the fastest-growing segment in clinical research, supporting the discovery of data for newer indications and new markets beyond the drug's initial approval.

These studies should be randomized to maximize informational value. The Phase IV research environment is driven by varying regulatory requirements, increasing safety concerns for new medicines, and the need for real-world data on marketed drugs.

Purpose

Phase IV studies form an integral part of the drug evaluation process and represent a promising phase of advancement for marketed drugs.